# Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study

> **NCT02562170** · PHASE4 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 50 (actual)

## Conditions studied

- Breast Cancer
- Hereditary Breast and Ovarian Cancer Syndrome

## Interventions

- **DEVICE:** TiLoop Bra
- **DEVICE:** Protexa

## Key facts

- **NCT ID:** NCT02562170
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2015-04
- **Final completion:** 2015-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02562170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02562170, "Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02562170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*